ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® DASH Insulin Management System ...
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System) ...
Insulet Corporation’s PODD Omnipod and Omnipod DASH insulin management systems recently received FDA’s approval for their use with Eli Lilly and Company’s LLY Lyumjev (insulin lispro-aabc injection) ...
Billerica, Massachusetts-based Insulet Corporation, maker of the OmniPod Insulin pump, has just announced that it received the FDA clearance to commercialize its latest product the Omnipod Dash ...
Insulet Corporation PODD announced the launch of the Omnipod DASH Insulin Management System (Omnipod DASH System) in Canada. Notably, the company plans to launch the Omnipod DASH System throughout ...
Omnipod 5 has been a major revenue catalyst for Insulet since its release. At the same time, operating expenses associated with Omnipod 5 are higher because of demand exceeding expectations. Higher ...
The US Food and Drug Administration has cleared Insulet's Omnipod DASH Insulin Management System, a major revamp of the tubing-free insulin delivery device for use in diabetes. The Omnipod, first ...
Insulet Corporation PODD is well-poised to gain in the coming quarters, backed by the strength of its revolutionary Omnipod 5 Automated Insulin Delivery (“AID”) system. The continued market expansion ...
Insulet Corporation PODD announced the launch of the Omnipod DASH Insulin Management System (Omnipod DASH System) in Canada. Notably, the company plans to launch the Omnipod DASH System throughout ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results